GIP
NVO

Granite Investment Partners’s Novo Nordisk NVO Stock Holding History

Granite Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-17,250
Closed -$267K – 255
2013
Q2 		$267K Buy
+17,250
New +$287K 0.05% 231

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SF
Sarofim Fayez Houston, Texas $20.5B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Granite Investment Partners's NVO Position: Q3 2013 in Review

Granite Investment Partners sold out of Novo Nordisk (NVO) in Q3 2013, closing a stake of 17,250 shares — an estimated $267K sold.

Granite Investment Partners first reported a position in NVO in Q2 2013 and held it in 1 quarter. The position peaked at $267K in Q2 2013. 425 funds tracked by Wall St. Rank hold NVO as of Q3 2013.

  • Granite Investment Partners reported no remaining Novo Nordisk position as of Q3 2013 after selling out during the quarter.
  • Granite Investment Partners sold 17,250 Novo Nordisk shares in Q3 2013, an estimated $267K.
  • Granite Investment Partners first reported a position in Novo Nordisk in Q2 2013 and held it in 1 quarter.
  • Granite Investment Partners's Novo Nordisk position peaked at $267K in Q2 2013.
  • 425 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2013.

Based on Granite Investment Partners's 13F filing for Q3 2013, filed 13 Nov 2013.